Overview
In this observational, retro-prospective, and multicenter PMCF clinical investigation, Biodentine™, an active dentine substitute for professional dental use only, is evaluated at 10 years post-treatment, in its endodontic indications as followed:
- Repair of root or furcation perforations.
- Repair of root resorptions (internal and external).
- Root-end filling in endodontic surgery (retrograde filling).
- Apexification (tooth with open apex).
- Revitalization procedure by means of revascularization.
Evaluation is done through a 10-year post-treatment follow-up with collection of radiographic, clinical examination and safety data.
Eligibility
Inclusion Criteria:
- Male or female, adult or child with permanent study tooth (immature or mature)
- Study tooth treated with an endodontic microsurgery using Biodentine™: all microsurgery including root end-filling, external or internal root resorption repair, root and furcation perforation repair and apexification
- Study tooth treated at least 1 year and no more than 5.5 years before inclusion visit
- Availability of baseline radiographic image of the study tooth
- Patient affiliated to national health insurance
- Patient informed about the study and who confirms his/her consent to participate to the study
Exclusion Criteria:
- Patient treated with anti-cancer therapy in the 5 years prior to the treatment
- Uncontrolled systemic disease 1 month prior to the treatment
- Development of a cancer or a systemic disease just after the treatment
- Participation to an interventional clinical trial at the time of the treatment
